Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
On December 19, the U.S. Court of Appeals for the Fifth Circuit filed an order vacating the Securities and Exchange Commission’s (SEC) share repurchase rule. This action officially kills the share repurchase rule, at least for now.
As previously discussed, the rule, which would have required SEC-registered reporting issuers to report daily share repurchase data and the reasons why issuers were repurchasing their stock, was challenged by plaintiffs, including the U.S. Chamber of Commerce, among others. The plaintiffs argued, among other reasons, that the SEC acted arbitrarily and capriciously in adopting the final rule.
In a ruling issued on October 31, the court agreed with the plaintiffs that the rule was arbitrarily and capriciously adopted as the SEC did not adequately respond to comments about the rule’s economic implications or adequately substantiate the rule’s benefits. The court gave the SEC 30 days to correct the defects identified. Following that, the SEC issued an order delaying the rule’s effectiveness on November 22, and then notified the court on December 1, that it was unable to correct the defects in the rule within the prescribed time. Thereafter, the plaintiffs filed a motion asking the court to vacate the rule, which the SEC indicated it would not challenge.
The court’s action, which was widely expected following the SEC’s December 1 admission, officially ends the drama surrounding the share repurchase rule. Issuers no longer have to worry about complying with the mandate to report daily repurchase activity, which was scheduled to begin for quarters ending after October 1, 2023. Though the rule is dead for now, the SEC could appeal the court’s decision (which appears unlikely), or repropose the rule in a way that addresses the concerns of the court.
Given the many recently effective rules proposed by the SEC, having one less new matter to worry about for the coming reporting season will doubtless be viewed as a nice holiday treat by most issuers.
This just in
Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
Speaking Engagements
PFAS for Decision Makers: Managing PFAS Risk in Today’s Deals – While Preparing for What’s Next
August 27, 2026 | 12:00 PM – 1:00 PM CT
Webinar
Firm Events
Cocktails and Networking During MEDevice Boston
August 26, 2026 | 6:00 PM – 8:00 PM ET
Lifted Restaurant
450 Summer St, Boston, MA 02210
Speaking Engagements
The 2026 Multifamily Maturity Cliff: Reading the $162 Billion Refinancing Wave and the Engagements It Will Generate
August 26, 2026 | 1:00 PM – 3:10 PM ET
Webinar